Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Author Correction: Rev1 contributes to proper mitochondrial function via the PARP-NAD+-SIRT1-PGC1α axis.

Fakouri NB, Durhuus JA, Regnell CE, Angleys M, Desler C, Hasan-Olive MM, Martín-Pardillos A, Tsaalbi-Shtylik A, Thomsen K, Lauritzen M, Bohr VA, de Wind N, Bergersen LH, Rasmussen LJ.

Sci Rep. 2018 Mar 6;8(1):4245. doi: 10.1038/s41598-018-20586-9.

2.

Rev1 contributes to proper mitochondrial function via the PARP-NAD+-SIRT1-PGC1α axis.

Fakouri NB, Durhuus JA, Regnell CE, Angleys M, Desler C, Hasan-Olive MM, Martín-Pardillos A, Tsaalbi-Shtylik A, Thomsen K, Lauritzen M, Bohr VA, de Wind N, Bergersen LH, Rasmussen LJ.

Sci Rep. 2017 Oct 2;7(1):12480. doi: 10.1038/s41598-017-12662-3. Erratum in: Sci Rep. 2018 Mar 6;8(1):4245.

3.

Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions.

Martín-Pardillos A, Tsaalbi-Shtylik A, Chen S, Lazare S, van Os RP, Dethmers-Ausema A, Fakouri NB, Bosshard M, Aprigliano R, van Loon B, Salvatori DCF, Hashimoto K, Dingemanse-van der Spek C, Moriya M, Rasmussen LJ, de Haan G, Raaijmakers MHGP, de Wind N.

Blood. 2017 Sep 28;130(13):1523-1534. doi: 10.1182/blood-2017-01-764274. Epub 2017 Aug 21. Erratum in: Blood. 2018 Feb 8;131(6):710.

4.

Post-translesion synthesis repair.

Jansen JG, Tsaalbi-Shtylik A, de Wind N.

Oncotarget. 2015 Aug 14;6(23):19342-3. No abstract available.

5.

When mismatch repair met translesion synthesis.

Tsaalbi-Shtylik A, Jansen JG, de Wind N.

Cell Cycle. 2015 Aug 3;14(15):2377-8. doi: 10.1080/15384101.2015.1063288. Epub 2015 Jun 23. No abstract available.

6.

De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Tomas-Roca L, Tsaalbi-Shtylik A, Jansen JG, Singh MK, Epstein JA, Altunoglu U, Verzijl H, Soria L, van Beusekom E, Roscioli T, Iqbal Z, Gilissen C, Hoischen A, de Brouwer APM, Erasmus C, Schubert D, Brunner H, Pérez Aytés A, Marin F, Aroca P, Kayserili H, Carta A, de Wind N, Padberg GW, van Bokhoven H.

Nat Commun. 2015 Jun 12;6:7199. doi: 10.1038/ncomms8199.

7.

Excision of translesion synthesis errors orchestrates responses to helix-distorting DNA lesions.

Tsaalbi-Shtylik A, Ferrás C, Pauw B, Hendriks G, Temviriyanukul P, Carlée L, Calléja F, van Hees S, Akagi J, Iwai S, Hanaoka F, Jansen JG, de Wind N.

J Cell Biol. 2015 Apr 13;209(1):33-46. doi: 10.1083/jcb.201408017.

8.

Roles of mutagenic translesion synthesis in mammalian genome stability, health and disease.

Jansen JG, Tsaalbi-Shtylik A, de Wind N.

DNA Repair (Amst). 2015 May;29:56-64. doi: 10.1016/j.dnarep.2015.01.001. Epub 2015 Jan 21. Review.

PMID:
25655219
9.

Persistently stalled replication forks inhibit nucleotide excision repair in trans by sequestering Replication protein A.

Tsaalbi-Shtylik A, Moser J, Mullenders LH, Jansen JG, de Wind N.

Nucleic Acids Res. 2014 Apr;42(7):4406-13. doi: 10.1093/nar/gkt1412. Epub 2014 Jan 23.

10.

Rev1 is essential in generating G to C transversions downstream of the Ung2 pathway but not the Msh2+Ung2 hybrid pathway.

Krijger PH, Tsaalbi-Shtylik A, Wit N, van den Berk PC, de Wind N, Jacobs H.

Eur J Immunol. 2013 Oct;43(10):2765-70. doi: 10.1002/eji.201243191. Epub 2013 Aug 5.

11.

Error-prone translesion replication of damaged DNA suppresses skin carcinogenesis by controlling inflammatory hyperplasia.

Tsaalbi-Shtylik A, Verspuy JW, Jansen JG, Rebel H, Carlée LM, van der Valk MA, Jonkers J, de Gruijl FR, de Wind N.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21836-41. doi: 10.1073/pnas.0909507106. Epub 2009 Dec 10.

12.

Mammalian polymerase zeta is essential for post-replication repair of UV-induced DNA lesions.

Jansen JG, Tsaalbi-Shtylik A, Hendriks G, Verspuy J, Gali H, Haracska L, de Wind N.

DNA Repair (Amst). 2009 Dec 3;8(12):1444-51. doi: 10.1016/j.dnarep.2009.09.006. Epub 2009 Sep 27.

PMID:
19783229
13.

Functional interactions between DNA damage signaling and mutagenic translesion synthesis at post-replicative gaps.

Jansen JG, Tsaalbi-Shtylik A, de Wind N.

Cell Cycle. 2009 Sep 15;8(18):2857-8. Epub 2009 Sep 1. No abstract available.

PMID:
19729992
14.

The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs.

Roos WP, Tsaalbi-Shtylik A, Tsaryk R, Güvercin F, de Wind N, Kaina B.

Mol Pharmacol. 2009 Oct;76(4):927-34. doi: 10.1124/mol.109.058131. Epub 2009 Jul 29.

PMID:
19641035
15.

Abrogation of microsatellite-instable tumors using a highly selective suicide gene/prodrug combination.

Ferrás C, Oude Vrielink JA, Verspuy JW, te Riele H, Tsaalbi-Shtylik A, de Wind N.

Mol Ther. 2009 Aug;17(8):1373-80. doi: 10.1038/mt.2009.114. Epub 2009 May 26.

16.

Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells.

Jansen JG, Tsaalbi-Shtylik A, Hendriks G, Gali H, Hendel A, Johansson F, Erixon K, Livneh Z, Mullenders LH, Haracska L, de Wind N.

Mol Cell Biol. 2009 Jun;29(11):3113-23. doi: 10.1128/MCB.00071-09. Epub 2009 Mar 30.

17.

Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice.

Jansen JG, Langerak P, Tsaalbi-Shtylik A, van den Berk P, Jacobs H, de Wind N.

J Exp Med. 2006 Feb 20;203(2):319-23. Epub 2006 Feb 13.

18.

The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis.

Jansen JG, Tsaalbi-Shtylik A, Langerak P, Calléja F, Meijers CM, Jacobs H, de Wind N.

Nucleic Acids Res. 2005 Jan 13;33(1):356-65. Print 2005.

Supplemental Content

Loading ...
Support Center